This NDC is on FDA's drug shortage list (posted Feb 22, 2012)
Product Information
LIDOCAINE HCL 2% VIAL is a generic product labeled by Hospira Inc., priced at $0.0762 per ML under NDC 00409427701. Its NADAC has been published 233 times since Nov 28, 2013.
FDA first approved this application on Jul 31, 1984. Its Orange Book therapeutic-equivalence code is AP.
Strength
20 mg/mL
Manufacturer
Hospira Inc.NDC
00409427701
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INFILTRATION; PERINEURAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA088327FDA Approved
7/31/1984
TE Code
AP
On Market Since
6/15/2005
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 2% VIAL has been published 233 times since Nov 28, 2013, and over the history we have for it it has declined 2.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0762 per ML |
|---|---|
| All-time high | $0.1254 (Sep 11, 2024) |
| All-time low | $0.0617 (May 17, 2023) |
| 52-week high | $0.0902 |
| 52-week low | $0.0762 |
| Median price | $0.0784 |
| Average price | $0.0810 |
| Largest weekly change | +103.3% (Jul 17, 2024) |
| Weeks tracked | 233 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LIDOCAINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 2% VIAL?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 2% VIAL, manufactured by Hospira Inc., is $0.0762 per ML (NDC 00409427701), effective Sep 30, 2026.
How has the price of LIDOCAINE HCL 2% VIAL changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 2% VIAL has declined 2.0%. It has been tracked across 233 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 2% VIAL?
Since Nov 28, 2013, the NADAC for LIDOCAINE HCL 2% VIAL has ranged from a low of $0.0617 (May 17, 2023) to a high of $0.1254 (Sep 11, 2024), with a median of $0.0784 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 2% VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 2% VIAL, is $0.0569 per ML — about 25% below LIDOCAINE HCL 2% VIAL.
Who manufactures LIDOCAINE HCL 2% VIAL?
LIDOCAINE HCL 2% VIAL (NDC 00409427701) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is LIDOCAINE HCL 2% VIAL in shortage?
Yes — NDC 00409427701 is currently listed in FDA's drug shortage database (posted Feb 22, 2012).